Company banner
company logo

Puma Biotechnology

Puma Biotechnology Careers, Jobs, and Salary Information

Find High Paying Jobs and Compensation Information at Puma Biotechnology

Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses and develops drug candidates for commercial use and is devoted to delivering innovative products to patients with cancer. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California. The company's lead product candidate is Neratinib, an orally active, irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. The company has additional drug candidates in various stages of development.
Size
196 employees
Market Cap
$220.6 million
Industry
Net Income
-$59.9 million
Founded
2010
Revenue
$225.1 million
NASDAQ
Total value of jobs icon
Total value of jobs:$7,357,500
Average Pay icon
Average Pay:$198,851

Similar Companies

Axsome Therapeutics, Inc. logo
Axsome Therapeutics, Inc.

Pharmaceuticals & Biotech

BlueRock Therapeutics logo
BlueRock Therapeutics

Pharmaceuticals & Biotech

Element Biosciences logo
Element Biosciences

Pharmaceuticals & Biotech

Pendulum™ logo
Pendulum™

Pharmaceuticals & Biotech

Entrada Therapeutics logo
Entrada Therapeutics

Pharmaceuticals & Biotech

Ovid Therapeutics Inc. logo
Ovid Therapeutics Inc.

Pharmaceuticals & Biotech

Kriya Therapeutics logo
Kriya Therapeutics

Pharmaceuticals & Biotech

eGenesis, Inc. logo
eGenesis, Inc.

Pharmaceuticals & Biotech

Pliant Therapeutics logo
Pliant Therapeutics

Pharmaceuticals & Biotech

AllazoHealth logo
AllazoHealth

Pharmaceuticals & Biotech